Dermira (NASDAQ: DERM) reported Q4 EPS of ($0.60), $0.13 worse than the analyst estimate of ($0.47). Revenue for the quarter came in at $16 million versus the consensus estimate of $16.57 million.

For earnings history and earnings-related data on Dermira (DERM) click here.